Damage classification and derivation of damage probability matrices from L’Aquila (2009) post-earthquake survey data von Rosti, A., Rota, M., Penna, A.

Volltext

Empirical fragility curves for Italian residential RC buildings von Rosti, A., Del Gaudio, C., Rota, M., Ricci, P., Di Ludovico, M., Penna, A., Verderame, G. M.

Volltext

An empirical seismic vulnerability model von Rosti, A., Rota, M., Penna, A.

Volltext

Validation of physics-based ground shaking scenarios for empirical fragility studies: the case of the 2009 L’Aquila earthquake von Rosti, A., Smerzini, C., Paolucci, R., Penna, A., Rota, M.

Volltext

Comparison of PSH results with historical macroseismic observations at different scales. Part 1: methodology von Rota, M., Rosti, A.

Volltext

Comparison of PSH results with historical macroseismic observations at different scales. Part 2: application to South-East France von Rosti, A., Rota, M.

Volltext

Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis von Rumi, Elisa, Pietra, Daniela, Pascutto, Cristiana, Guglielmelli, Paola, Martínez-Trillos, Alejandra, Casetti, Ilaria, Colomer, Dolors, Pieri, Lisa, Pratcorona, Marta, Rotunno, Giada, Sant'Antonio, Emanuela, Bellini, Marta, Cavalloni, Chiara, Mannarelli, Carmela, Milanesi, Chiara, Boveri, Emanuela, Ferretti, Virginia, Astori, Cesare, Rosti, Vittorio, Cervantes, Francisco, Barosi, Giovanni, Vannucchi, Alessandro M., Cazzola, Mario

Volltext

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia von Hochhaus, Andreas, Larson, Richard A, Guilhot, François, Radich, Jerald P, Branford, Susan, Hughes, Timothy P, Baccarani, Michele, Deininger, Michael W, Cervantes, Francisco, Fujihara, Satoko, Ortmann, Christine-Elke, Menssen, Hans D, Kantarjian, Hagop, O’Brien, Stephen G, Druker, Brian J

Volltext

Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus von Cairo, Mitchell S., Coiffier, Bertrand, Reiter, Alfred, Younes, Anas

Volltext

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias von Cortes, J.E, Kim, D.-W, Pinilla-Ibarz, J, le Coutre, P, Paquette, R, Chuah, C, Nicolini, F.E, Apperley, J.F, Khoury, H.J, Talpaz, M, DiPersio, J, DeAngelo, D.J, Abruzzese, E, Rea, D, Baccarani, M, Müller, M.C, Gambacorti-Passerini, C, Wong, S, Lustgarten, S, Rivera, V.M, Clackson, T, Turner, C.D, Haluska, F.G, Guilhot, F, Deininger, M.W, Hochhaus, A, Hughes, T, Goldman, J.M, Shah, N.P, Kantarjian, H

Volltext

Factor analysed hidden Markov models for speech recognition von Rosti, A-V.I., Gales, M.J.F.

Volltext

Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia von Saglio, Giuseppe, Kim, Dong-Wook, Issaragrisil, Surapol, le Coutre, Philipp, Etienne, Gabriel, Lobo, Clarisse, Pasquini, Ricardo, Clark, Richard E, Hochhaus, Andreas, Hughes, Timothy P, Gallagher, Neil, Hoenekopp, Albert, Dong, Mei, Haque, Ariful, Larson, Richard A, Kantarjian, Hagop M

Volltext

Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population von Efficace, Fabio, Baccarani, Michele, Breccia, Massimo, Alimena, Giuliana, Rosti, Gianantonio, Cottone, Francesco, Deliliers, Giorgio Lambertenghi, Baratè, Claudia, Rossi, Antonella Russo, Fioritoni, Giuseppe, Luciano, Luigia, Turri, Diamante, Martino, Bruno, Di Raimondo, Francesco, Dabusti, Melissa, Bergamaschi, Micaela, Leoni, Pietro, Simula, Maria Pina, Levato, Luciano, Ulisciani, Stefano, Veneri, Dino, Sica, Simona, Rambaldi, Alessandro, Vignetti, Marco, Mandelli, Franco

Volltext

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia von Hochhaus, A, O'Brien, S G, Guilhot, F, Druker, B J, Branford, S, Foroni, L, Goldman, J M, Müller, M C, Radich, J P, Rudoltz, M, Mone, M, Gathmann, I, Hughes, T P, Larson, R A

Volltext

A SoC Design Methodology Involving a UML 2.0 Profile for SystemC von Riccobene, E., Scandurra, P., Rosti, A., Bocchio, S.

Volltext

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study von Larson, Richard A., Druker, Brian J., Guilhot, Francois, O'Brien, Stephen G., Riviere, Gilles J., Krahnke, Tillmann, Gathmann, Insa, Wang, Yanfeng

Volltext

Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy von Lorch, Anja, Beyer, Jörg, Bascoul-Mollevi, Caroline, Kramar, Andrew, Einhorn, Lawrence H, Necchi, Andrea, Massard, Christophe, De Giorgi, Ugo, Fléchon, Aude, Margolin, Kim A, Lotz, Jean-Pierre, Germa Lluch, Jose Ramon, Powles, Thomas, Kollmannsberger, Christian K

Volltext

Donde no habite el olvido: herencia y transmisión del testimonio : perspectivas socio-jurídicas von Paleari, Valentina, Rosti, Marzia

Volltext

A model-driven design environment for embedded systems von Riccobene, E., Scandurra, P., Rosti, A., Bocchio, S.

Volltext

Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial von Cortes, Jorge, Apperley, Jane, Lomaia, Elza, Moiraghi, Beatriz, Undurraga Sutton, Maria, Pavlovsky, Carolina, Chuah, Charles, Sacha, Tomasz, Lipton, Jeffrey H., Schiffer, Charles A., McCloskey, James, Hochhaus, Andreas, Rousselot, Philippe, Rosti, Gianantonio, de Lavallade, Hugues, Turkina, Anna, Rojas, Christine, Arthur, Christopher Kevin, Maness, Lori, Talpaz, Moshe, Mauro, Michael, Hall, Tracey, Lu, Vickie, Srivastava, Shouryadeep, Deininger, Michael

Volltext